or Try an Advanced Search...

    Technical Analysis for ABIO - ARCA biopharma, Inc.

    Grade Last Price % Change Price Change
    B 3.70 6.63% 0.23
    ABIO closed up 6.63 percent on Friday, May 31, 2024, on 4 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ABIO trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 6.63%
    Narrow Range Bar Range Contraction 6.63%
    Doji - Bearish? Reversal 4.23%
    Gapped Up Strength 4.23%
    Up 3 Days in a Row Strength 4.23%
    Up 4 Days in a Row Strength 4.23%
    Oversold Stochastic Weakness 4.23%
    Crossed Above 20 DMA Bullish 9.14%
    Stochastic Buy Signal Bullish 9.14%
    Up 3 Days in a Row Strength 9.14%
    Older End-of-Day Signals for ABIO ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    20 DMA Support 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ABIO Chart by TradingView
    Basic chart:

    Profile

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction

    Is ABIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 ARCA biopharma GAAP EPS of -$0.14
    Apr 25 ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
    Apr 3 Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details
    Apr 3 ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction
    Apr 3 ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
    Dec 20 We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
    See more ABIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.49
    52 Week Low 1.56
    Average Volume 1,820,317
    200-Day Moving Average 2.14
    50-Day Moving Average 3.10
    20-Day Moving Average 3.41
    10-Day Moving Average 3.39
    Average True Range 0.26
    RSI (14) 60.78
    ADX 30.72
    +DI 29.68
    -DI 16.52
    Chandelier Exit (Long, 3 ATRs) 3.70
    Chandelier Exit (Short, 3 ATRs) 3.88
    Upper Bollinger Bands 3.80
    Lower Bollinger Band 3.03
    Percent B (%b) 0.87
    BandWidth 22.63
    MACD Line 0.10
    MACD Signal Line 0.11
    MACD Histogram -0.0085
    Fundamentals Value
    Market Cap 53.65 Million
    Num Shares 14.5 Million
    EPS -0.37
    Price-to-Earnings (P/E) Ratio -10.00
    Price-to-Sales 0.00
    Price-to-Book 0.65
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.11
    Resistance 3 (R3) 4.08 3.91 4.04
    Resistance 2 (R2) 3.91 3.81 3.93 4.01
    Resistance 1 (R1) 3.81 3.75 3.86 3.84 3.99
    Pivot Point 3.64 3.64 3.67 3.66 3.64
    Support 1 (S1) 3.54 3.54 3.59 3.57 3.41
    Support 2 (S2) 3.37 3.48 3.39 3.39
    Support 3 (S3) 3.27 3.37 3.36
    Support 4 (S4) 3.30